Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

IT stocks lead the gains
Wed, 12 Oct 09:30 am

Asian stock markets have opened the day on a mixed note. Stock markets in China (up 2.2%), Indonesia (up 1.4%) and Malaysia (up 0.6%) are leading the gains. However, markets in Japan (down 0.7%) and Taiwan (down 0.1%) are trading weak. The Indian stock market have opened the day on a firm note. Stocks in the Information Technology (IT) space are leading the gains. However, auto stocks are trading in the red.

The BSE-Sensex is trading higher by around 166 points (1%), the NSE-Nifty is up by around 50 points (1%). Mid and small cap stocks have opened on a positive note as well with BSE Mid Cap and BSE Small Cap indices up by 0.6% and 0.5% respectively. The rupee is trading at 49.45 to the US dollar.

Power stocks have opened the day on a firm note with Jaiprakash Power, Reliance Infrastructure and GVK Power and Infrastructure leading the gains. However, National Thermal Power Corporation (NTPC) is trading in the red. India's power generation has suffered to quite an extent due to the shortage of coal. Unfortunately, there is little chance that the scenario will change anytime soon. On account of severe decline in coal supply from Coal India and its subsidiaries, the country has lost about 4 bn units (bu) of power generation between April and September, 2011. According to the power ministry, Coal India and its subsidiaries were expected to produce 347 m tonnes (mt) of coal in the financial year 2011-12. However, is seems that the coal producer will be able to achieve only 310 mt. During 2010-11, there was a loss of 10 bu in power generation.

Pharma stocks have opened the day on a strong note with Sun Pharma, Aurobindo Pharma, Piramal Healthcare and Cipla trading firmly in the green. Indian pharma major Lupin announced that it has launched a generic version of Femcon Fe in the US market. Femcon is a birth control chewable tablet and is launched from the US subsidiary of Lupin. The drug is the generic version of Warner Chilcott's Femcon Fe Chewable tablets and is introduced in strengths of 0.4mg/35mcg. The group president of Lupin, Mr Nilesh Gupta said that the company is looking forward to the opportunity to commercialise the authorised generic for Femcon. He also added that the consumers can be assured that the product's quality would not be compromised despite its cheaper price.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "IT stocks lead the gains". Click here!

  
ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Agora Research Private Limited.

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Agora Research Private Limited (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.